Claudia von Boeselager (02:20)
Jay, welcome back to the Longevity and Life Sub Podcast. Such a pleasure to have you back on.

Jay Campbell (02:24)
Claudia, thank you so much. It's an honor to be here.

Claudia von Boeselager (02:26)
I loved our first conversation. So for those of you who haven't checked it out yet, make sure to. Today we're going to focus on biolongevity supplements. And Jay, as I'm sure you hear very often, everyone's like, another supplement company. Please explain why you founded biolongevity supplements and what's the difference with the other players in the market.

Jay Campbell (02:43)
Yeah. So the very truth is there really are no competitors to the products that we sell other than one company, and that is Level Up Supplements. And if you're familiar with Kyle, who owns Level Up, he's a friend of mine. He does a great job. He has a great business. They have great products. In fact, he built his business before we launched BLL. So again, shout out to him and Kyle. I see you soon. I'm sure I will at one of the conventions or the seminars. What's up, my bro? great job and all the work you're doing. But we launched BioLongevity Labs in

Claudia von Boeselager (03:03)
Yeah.

Jay Campbell (03:07)
Technically December of 2024. And in the last 17 or 18 months, as we've ascended, in the space from a standpoint of like sales volume, PR, brand equity, etc. And again, shout out to my team. They've done an incredible job from literally going from zero to hero because now we're just doing so well. And I mean, honestly, like for anybody who wants to fact check me.

They can look into our SEO rankings and they will see that we're in like the top three of any peptide company on the planet. So again, shout out to my team. They're absolutely ninjas in everything they do. But you know, our credit card processors started asking us, look, you guys are talking about, you know, human use supplements because you have bioregulators, which, as you know, are the Russian bioregulators from Cabinson, which are considered nutraceuticals.

By all the regulatory governing bodies. So the FDA, you know, the various other regulatory bodies in Europe. and so we're selling them, but we're also then selling them with research peptides, which again are considered RUO, research use only, or even direct to consumer, as our attorneys would say about it. And they were just saying that it's becoming harder and harder for us to legally defend that you aren't, you know, implying human use by selling the supplements when you also are selling the direct to consumer.

Research peptides for research purposes. So the bottom line is we just decided internally amongst the owners to separate the site. So, you know, for full disclosure, we've had the supplements on the actual Biolongevity Lab site since we launched the company. And obviously we've been iterating and iterating and iterating. And that's why I say we have the best products on the planet. But it wasn't until June fourth of this year. So literally now, almost officially a month, we've separated it. So now that biolongevity supplements.com is its own site.

And it will also ultimately at some point, Claudia, have its own 3PL and distribution. Right now, everything is still shared, but as we continue to separate them and create them as separate entities, they will be separate companies. And for the end user, you know, because I want to talk about this because I think it's important. the regulatory oversight right now of peptides in general, from compounded versions to

pharmaceutical manufacturers and then of course into our space, which is again considered RUO or direct to consumer, is very, very, very tumultuous. It's very nebulous. just Monday of this week, and I know today's Thursday, and I don't know when this is going to run, but obviously today's Thursday, July second, they actually announced, which is insane that they would tip their hat, that they're not gonna approve any of the class two peptides to class one.

even though they're convening to meet to discuss them. So I mean it's literally a sham. Let's just be honest. This is a sham meeting. It's a sham.

Claudia von Boeselager (05:32)
Yeah. What a hundred percent

and it's such a pity It's so frustrating. what is your take on why that came out on Monday?

Jay Campbell (05:40)
just for the record, I called this. I mean, I've been telling every single person in the space what was going to happen because I saw this myself in 2017 with hormones. In 2017, by the way, they have a very official and sanctioned playbook, and they never change it and they always run it, right? And it was in 2017 they asked me to come to the same Washington, DC.

Focus group on hormones. You know, you've done so much work on men's testosterone and therapeutic hormones and women's too. And, you know, we want thought leaders like you to come. And, you know, they sent me a snail mail. They called me. Of course, this is, you know, way back in the early days of the internet. And I was all excited. I was like, Claudia, I'm being recognized by the establishment. And one of my doctor friends called me, and you know, I'll name him Dr. Rob Common Ark. Shout out to Dr. Rob. He said, Jay, please.

Claudia von Boeselager (06:23)
Yes, finally. Yeah.

Jay Campbell (06:31)
For the love of God, trust me when I tell you this. Do not go. You will be ruined. They will literally diminize you. They will literally sit up there in their stodgy, you know, overcoats and say, Do you have any human studies? And it'll just be nonstop. And you'll be smeared and you may never recover. And so, you know, I listened to him, thankfully, and here we are.

It was only in April of this year, nine years later, I might add, that they finally came out with a consensus prescribing indication for the veterans administration. So nine years later, Claudia, they're finally, finally approving therapeutic hormones for veterans, but all you have to do is actually look at the clinical use case and the indications. And it's so tightly still restricted, it's a joke.

Claudia von Boeselager (07:07)
Nine years. Crazy.

It's a joke. Yeah.

Jay Campbell (07:22)
So, I mean, again,

what are they gonna do for peptides? They did the exact same thing now with this pharmacy committee, you know, meeting, which is July 23rd and July 24th, and then there's gonna be sometime in February. But I mean, it's so insane. They actually leaked the documents on Monday. And so the smart people, which by the way, there are not many left, saw that they're not going to approve them. So let me just say this because this is even more insane.

RFK, and I don't know if it's actually RFK, and shout out to RFK and Maha, because obviously they're doing lots of work. But somebody on Instagram and TikTok is promoting that he hired all these peptide-friendly doctors to be on these committees. It's all over social media because obviously many people have sent them to me and sent me the video clips and stuff. And I'm thinking, what is going on? You've got

Claudia von Boeselager (08:08)
Mm-hmm.

Jay Campbell (08:12)
The FDA telling people that they're not going to approve, they don't have enough human use, and yet you've got RFK and Maha telling people that it's going to be, you know, great for peptide prescribers. So it's really to me a joke. Like, I don't really know at this point like who to trust, but I definitely can tell you that the FDA already told everyone they are not going to recommend any of these peptides for

class one. And let me just say this too, because this is the most important thing. And this is what I've been saying. And it's so obvious to me now that this is going to happen. And obviously it's my opinion. I could be wrong, but I don't see it. They are going to then have the other meeting, of course, in February. And then they'll deliberate. And six months will go by because remember they don't do anything in any kind of speed. And then they'll come out and they'll say, well, after careful deliberation and consideration,

We're not, as we originally advocated, because there's no human studies. I mean, of course, right? But but to allow these, say, seven out of the nine peptides to be available, we're going to say that they're okay for this clinical diagnosis. And then they'll give seven companies, or maybe eight companies, or maybe it'll be four, and they'll each get two, the patent rights to change the molecules so that they can now have them as FDA approved drugs.

But remember, they will only be used if that person is given that diagnosis. So it's literally a giant scam, again, for the pharmaceutical manufacturers to control the distribution and manufacturing of peptides versus allowing the compounded industry or the obviously the research industry to sell them as they're doing now. So I mean, again, I tell people all the time, you gotta really interpret and read between the lines because it's definitely not favorable. It's just not.

Claudia von Boeselager (09:56)
And for people who are maybe unfamiliar with this, it's looking at, you know, follow the money as they say, right? So who is incentivized by because peptides are so powerful, maybe you can explain for people who are new to this topic But they're so powerful and so many, obviously you need to get the foundations right, etc. It's you know, later on in the food chain of getting your health back on track, but people are not getting sick then. And so if you're not getting sick, well, who's impacted? And who doesn't want you to not get sick? Who doesn't want you to be chronically ill?

Hmm, you know, and who's also funding the FDA? Hmm. And so it's understanding some of these dynamics that are going on behind the scenes. And I think it's so important for people to read between the lines as you're saying, to understand there is a machinery in the background going on where incentives are very much advocated for or against so unfortunately to the detriment of the people who need it and the potential use of day-to-day life. So let's take a step back for a moment, Jay, or maybe you want to comment on that and then

Jay Campbell (10:24)
Exactly.

Claudia von Boeselager (10:48)
actually explain what peptides are and that this isn't some crazy molecule, but it's been used in Russia in the nineteen eighties and there are actually trials on humans from back then. maybe you can expand a little bit for people listening so they better understand it.

Jay Campbell (11:02)
I wanna add something. So this is today, by the way. This is actually in the news today, July second. The CBS News, they interviewed our attorney, Jeff Cohen, yesterday, and he actually called me and gave me a heads up, was like, dude, you're not gonna believe this. But they are selling Retatrutide which as you know is the stage three GLP, which is not yet formally FDA approved, but of course it's been in the research use community for three years. as anybody in peptides is using it 'cause it's the greatest drug ever, et cetera. But

They're selling it out of bodegas in New York City right now. And they're selling it for $75 to $85 per 10 milligram. And evidently people have tested it and it's real. So the reason I'm bringing this up is they even in the article, it clearly is a pharma-controlled article and interview because they actually have people, staff from the FDA, commenting in the article. And they're saying things that if you're reading between the lines,

That's not good. And what I mean by not good is going back to what you just said, that the end the end use or the end outcome for the end user, whether it's a patient or a researcher, is that they're going to heavily restrict these products. And sadly and unfortunately for the majority of humanity, because as you know, less than 90% of people have no idea what a peptide is. And we'll get to that in a second. But they are going to the ones that are going be suffering for this because they are going to restrict.

Claudia von Boeselager (12:13)
Mm-hmm.

Jay Campbell (12:18)
The use of these. And not only are they going to restrict the use of these, they're going to dramatically skyrocket the price as Eli Lilly, you know, controls the process and controls the production. And again, look, you know, if I'm gonna sit here and I'm gonna be an evangelist for the pharmaceutical companies, and I'm happy to do that because they have great formulators and molecular engineers and biochemists that are creating these amazing products. And as I've said, you know, in my book, which came out this year in February.

Metabolic awakening with GLP peptides, I said we're in a golden age of these molecules, right? And then there's only going to be better things coming. So shout out to them for what they're doing,

Jay Campbell (12:51)
They care about making money.

the truth is that they're going to heavily restrict peptides. The article itself, which I'll send to you after this interview, clearly indicates that because the FDA is making comments in the article saying that we are going through.

legal channels to stop you know the unlawful sale of these products, etc. So you can only see what's coming. And again, I bring that up because I want people to understand that as you said, at the end of the day, the people that are harmed most by this are the end users who have never experienced the wonder of peptides. Because again, Retatrutide is an amazing, you know, triple stage agonist, you know, call it GLP, and it does amazing things for brain health, metabolic health.

physical functioning, energy production. There's so many great things it does for people that use it correctly. so it's just very strange time to be in the peptide space, to be like me, you know, involved in manufacturing and selling and seeing and reading the tea leaves and seeing like the legal maneuvering and the stuff that's happening. And like I said, going back to the whole pharmacy committee and then hearing a conflicting message coming out of RFK and the Maha camp. It's just a bizarre world that we're in. But

Yeah, Chip Chip, just to get back to your question, peptides are just chains of amino acids. They're essentially signaling molecules in the human body. And they're based on the length of the amino acid chain determines on how you use them from a delivery system standpoint. Like a shorter chain of amino acid sequence is like an oral bioregulator that you can consume. You know, though I have actually one like right here in my office right now, and so you can take these orally

The longer the chain, the more likely you have to inject it. And obviously also injecting is the highest impact delivery system, right? So if you inject a peptide, two things happen. It crosses the blood brain barrier the fastest. And then number two, because it does that, it gets into what is called systemic or portal circulation so that it can deliver its effects as a signaling molecule to whatever it's attempting to you know heal or fix I guess attend to in the human body. So

Claudia von Boeselager (14:49)
Support. Yeah. Mm-hmm.

Jay Campbell (14:52)
That's kind of what peptides really are.

Claudia von Boeselager (14:53)
So in an ideal world, Jay, what would you say if regulation is different? Or even, I mean, look at Russia. I had a Dr. Alexander Grinberg, I don't know if you know him, he based out of San Francisco right now, but he was in clinical trials in Russia back in the nineteen eighties. And

Jay Campbell (15:07)
I do know who

he is. I'm not familiar with him in person, but I do know his name.

Claudia von Boeselager (15:11)
Yeah, yeah, I had them on the podcast too. And I think that it's so important for people to realize like this is not some person in a lab trying out something. Like these have been around a long time and then they're short chain aminos. It's not even like there's some, you know, new chemical coming into the body And they're so potent and powerful. In an ideal world, what would the landscape look like, Jay, if you had a magic wand? What would you like to see?

Jay Campbell (15:31)
I wanna address that because you know, there's a lot of very famous people, you know, putting a lot of real hate and vitriol into the market about there's no human use or there's no studies or anything. And as you and I both know, it's complete nonsense. now with AI we can translate a lot of the Russian research, we can translate the Bulgarian research. Listen, there's a gal named Yanna Sagaba who works for us now.

Who came to me, she's like in her mid-30s and she's like worked with Dr. Cavent, you know, and she's now in the States and her husband emigrated here. And she's like a master, massive bioregulator researcher. She's absolutely brilliant. You know, I've had many conversations with her. You should probably actually do a podcast with her. I'll connect you with her. But she's gonna be doing a lot of videos on demonstrating how to use bioregulators, how to stack them, you know, what's the current use case.

Claudia von Boeselager (16:09)
I'd love that.

Jay Campbell (16:16)
You know, how to take them correctly, because there's so much misinformation. But it really does bother me when I hear people say there's no human studies and peptides, because that's a joke. And by the way, you said 80s. I got news for you. It goes back to the 50s. So they've been using these for a long time. I mean, like they're over-the-counter remedies in in Russia. And, you know, they know how to use them systemically. And again, as she told me when I first started talking to her, she's Look, man, I don't want to

Claudia von Boeselager (16:16)
Brilliant.

Mm-hmm.

wow.

Jay Campbell (16:40)
you know, demean your work or anything like that. But she's like, you guys are clueless, like compared to like Russia. She's like, these are nothing, you know. And by the way, it's crazy, and I have to say this, but people don't understand this. In Russia, health optimization is the standard. There is no sick care medicine. Like every healer and physician in Russia uses bioregulators as first line, peptides as first line. Whereas in this country,

Claudia von Boeselager (16:44)
Yeah.

Mm-hmm.

Jay Campbell (17:06)
Doctors are literally trained that peptides are voodoo, that there's no human studies, that giving them to people can cause side effects and symptomology. I mean, look, I'll just tell you this. The poor football player, Chris Johnson. you know, the big story on Monday, he's got ALS. He's this great running back. He played for the Nashville, whatever their team is called. And

Poor guy is seemingly an amazing soul. He's probably like an archangel come back because I was listening to his talk, and all he can use is the computer, right? Because he's lost all the function of his body. And you know, my team, we heard about this on Monday and we mobilized. I put all my chemists immediately into action. I said, design a stack, I don't care what it costs, I'll pay for it. Get it, we're gonna get it to him. And so in the last three or four days, I've been reaching out to NFL player personnel directors.

Everybody that I have in my network, I mean, I know so many people in the NFL system, and do you realize they will literally refuse us? They refuse us. The guy is going to die. And because we do not represent conventional medicine and we don't have, you know, the studies of of big pharma behind us or, you know, drugs that are controlled by, you know, ALS research, they won't even consider it.

Claudia von Boeselager (17:57)
Yeah.

Jay Campbell (18:12)
So, like we were literally stymied this morning. So, I mean, I'm so hot and bothered by this because this man, we know for a fact that we could probably extend his life. We probably could also give him, you know, and his family a little bit more time. Again, I'm not gonna say we can reverse it because I don't know the progression. He's also taken a lot of hits to his head. He's probably got a lot of issues from all the trauma and the physical impacts. But again, we definitely know that we have products.

Claudia von Boeselager (18:17)
Yeah.

Mm-hmm.

Jay Campbell (18:39)
that would address the issues going on in his brain, you know, and also his central nervous system, which again is what ALS is. But they nope, absolutely not, Claudia. Absolutely not.

Claudia von Boeselager (18:42)
Mm-hmm.

and it's really tricky because it's some of the work I do with LUMARA Collective also, it's very cookie cutter system. I mean, even for some of the brain training and diagnostics, the team owners don't even wanna know about it because they don't want them to know about the brain injury that their team players are going through. And I've you know, former NFL players and it's a huge concern from the ALS to the Parkinson's dementia.

Jay Campbell (18:58)
Yes.

The biggest thing is CTE. In fact, you know, I won't say the names of the people, but they had a meeting scheduled with me today after this podcast. And when they knew that I wasn't going to give them for something that would address CTE, they cancel it. So it's like it's CTE in the NFL or bust. And it's really sad because, like I said, this guy, we know that we can do it. But the bottom line is one of my chemists is making something to address ALS.

Claudia von Boeselager (19:23)
Mm-hmm.

Mm-hmm.

Jay Campbell (19:31)
And

that's what's so cool that came out of this. So whether Chris Johnson lives or dies, we are going to make a product that will address ALS because right now they have nothing. They have absolutely nothing to solve it, to address it. They don't have any money and research. I mean, it's all sickening, but you know, it is sometimes these are the kind of unfortunate things that have to happen to mobilize people to do better or to do good. But you know, my chemist is like so motivated. He watched that video about him because it was on Good Morning America. They circulated it on Monday and it was it's it's very, very sad.

But this guy is clearly like positive and you know, he's like, hey man, if I can get one extra minute with my wife and kids, I'm good. And you know, he's such a brilliant communicator. I mean, it was depressing to watch it, but like I said, it mobilized us, and now we're building something for that. So that's what's cool. And I think if there's a bigger message, I definitely know there's a guy on X named Anthony Lenares, I forget his X handle, but you know, he's been talking about iterative mapping.

And iterative mapping is using AI to map every single amino acid sequence that is known to man that would actually create from like a lock in a key mechanism, the ability to, you know, handle, if not solve, a disease progression or like a in a cancer cell, like an oncological mutation of a cell, they could actually develop like a targeter that would unlock the actual mutation.

So you could technically reverse cancer. And they're really looking at this now, and they're spending lots of money in AI to decode all these different sequences. And he says it's only two years away. In fact, he said it would be shorter, but the problem is, we can't obviously commercially manufacture these peptides because they're all done in China. You know, that's what people have to understand. They have no ability to synthesize and sequence these amino acid chains because we did not have the manufacturing process. And

Again, I tell people this all the time, and this is things that I've learned in the last three years. But the reason it's all in China, it's also in India. But by the way, pharma controls the supply chain in India completely. They have non-compete, they can't do anything. There's no peptides that are going into research or for research purposes coming out of India because pharma controls it. But out of China they do. And they also obviously China also gets the compounded bulk formulations for 503A's and Bs. But the truth is that it costs.

A fortune, Claudia, to destroy peptide waste. So that's why we can't do it in the States, because obviously elimination is such a heavy fee. And I think we all know in China they don't care. We'll just dump it, you know, wherever. You know what I mean? And so that's what's actually happening in China, whereas they can manufacture peptides in bulk because they're not so, you know, caught up in the actual elimination of the actual peptide waste because it is bioactive contamination.

Claudia von Boeselager (21:40)
Mm.

Jay Campbell (22:02)
And so you have to incinerate it and again from a cost perspective, it costs a lot of money to do that correctly.

Claudia von Boeselager (22:08)
And the pollution Yeah. we'll talk offline actually I had a recent conversation with German researchers who have a DNA RNA test. Also, they have a case study with someone with ALS that were not mobile anymore, that now live independently, albeit with care, because of the DNA RNA test. And then you can do the personalized peptides, nutrition, protocols, etc. So we can have a separate conversation about this too. And I think

obviously ideally everything would be done in America, right? And it's all there. But I think sometimes it's important to think globally so that there is more flexibility and it's understanding what to look out for. How do you have quality, et cetera? But you know, looking at places like Russia, who they're brilliant scientists for many, many years. I mean, if you just look at history and ignore a little bit the current political climate just to, you know, understand things in a larger scale, you know, this is basic human health care, not sick care.

that we should all be having access to. And it's just very unfair that certain jurisdictions are being manipulated by big pharma and money trails, et cetera, without having people access to the things that would really benefit them in their lives Right.

Jay Campbell (23:06)
I probably shouldn't say it, but you me, I'm Jay Campbell, so I'll say it anyway. But I actually heard that the FDA, through I'm sure under the influence of Eli Lilly, because Eli Lilly benefits from this, is literally now going to China and paying off the, you know, call it underground manufacturers of retatrutide So they want to shut down all.

manufacturing and production of retatrutide again call it bootleg because that's what it is let's be honest right you know research molecule format so that they can actually just completely constrict or restrict you know the future selling of it and that would obviously not be out of the realm of possibility. I can't prove that I heard that from very high levels of people inside, you know, call it the chain of command. But again, if you read the article, which again I'm gonna send to you after this interview in

Claudia von Boeselager (23:50)
Please and we'll

link it in the show notes for everybody if you're interested. Yeah.

Jay Campbell (23:52)
Yes,

I mean it literally the marching orders of the FDA and Eli Lilly are in the article. Like they're basically saying, hey, we wrote this article. So if you're somebody right now, and by the way, I need to say this, there are actual pharmacy companies, manufacturers of compounded 503A and B selling retitrutide, which is multiple felonies. that is like it's one thing to be a research company making a research molecule.

But when you're in a food and drug, you know, under the governance of the Food and Drug Administration manufacturer like a 503B compounder and you're making Reditrutide, dude, like you are asking to go to jail, to be fined, to have IRS penalties and fees. I mean, I can only imagine stuff. So if you're doing that right now and you're in the space and you are literally selling, let's just say, volume of retitrutide, you are in.

Real trouble. And what I mean by that is the federal government, I would say the Department of Justice and the FBI is probably going to be activated and mobilized, and they're probably going to come after anybody who sold it. Because again, remember the rule is the law is if the FDA approves retatrutide in say end of third quarter or fourth quarter of this year, they can retroactively go back to Jan 1 and they can enforce.

Claudia von Boeselager (25:08)
Well.

Jay Campbell (25:10)
The illegal use and sale of the product, which again, there are thousands, if not tens of thousands, of people in this world right now, and it's not us. Because we stopped in December of last year when our attorney said stop selling it, who are still selling it and are obviously selling it, you know, knowing that Eli Lilly is watching. I mean, again, we call it you're on a naughty list. You know, and again, this is not just research. You know, people think it's research, shady.

Blah blah blah. It's not, it's compounded pharmacies. They're selling it. So it is a circus of like illegal proportions. And I believe after reading the article today, and I've kind of always known this because obviously the advice that I get from my council, that they were going to come with the full force of the United States system of jurisprudence. And believe me, they are. And I would say it's going to get really weird.

In the late third or early fourth, if not all of fourth quarter of this year in the pharmaceutical industry, because Eli Lilly is going to govern with an iron fist. And you know, the other thing that we is kind the canary in the coal mine is like, what about all the people selling semaglutide and tirzepatide which obviously SEMA is owned by Novo Nordisk from a patent and trademark standpoint. And then Lilly also owns terzapotide, which by the way is right now the number one selling drug in the world.

But what about the people selling those illegally? Are they gonna go after them too? I mean, you know, flip a coin, but they're clearly gonna go after everybody selling Reddit, because that's gonna be the money train. But my guess is they are gonna go after from an enforcement standpoint, people selling SEMA or selling TURS. And remember, you know, the compounders that are selling it don't have a legal right to do so anymore.

Claudia von Boeselager (26:32)
Problem.

Jay Campbell (26:50)
Because they don't have emergency use case declaration behind them. That was turned off in 2024. But if you interview a lot of these compound pharmacies, they're gonna say, well, you know, they gave me the right to sell it in 2023 and 24 when you know when there was an emergency use case because they couldn't manufacture it fast enough. And so I just didn't turn it off. And we're like, Well, that's not how the laws are written. So I don't know, dude. The whole pharmaceutical space to me is really a circus.

obviously the research space too is a circus. There are so many people selling fake products. In the article today in CBS News, the Bodega, they you know, they talked about the label of the vials and what website it traces back to. And they actually called the company that you know supposedly in issues the COA, the certificate of authenticity. And of course they say, we've never issued a certificate of authenticity to this company. they have no business with us. So

Claudia von Boeselager (27:20)
Mm-hmm.

Jay Campbell (27:41)
It's like I say, and I've been saying this literally for a year. 75% of products sold in the research use market right now are either fake, underdosed, counterfeit, or God only knows what. Because they have fake certificates of authenticity, they have fake chains of custody and lot numbers, I mean batch numbers. I mean, it's a sham. So if you're an end user using research chemicals right now, you've

Claudia von Boeselager (27:44)
Mm-hmm.

Jay Campbell (28:07)
Be doing your homework and your due diligence before you buy, making sure that what you're putting in your body is legit because a lot of it is fake. Now, I do think, Claudia, it's important to say that I think I said this to you on the last call. Thankfully, peptides are pretty innocuous, right? They're relatively harmless. You don't find people ODing, right? Like I've had friends say to me, when does fentanyltrutide come out? You know, clearly it's not in the market yet, but that's the only thing.

Claudia von Boeselager (28:31)
Yeah.

Jay Campbell (28:36)
In my opinion, preventing us from having a real serious issue is that these peptides, even if they are fake, underdose, low quality, whatever counterfeit, they don't cause problem, right? Because most people are probably injecting manitol or, you know, acrobose or, one of the what do you call it, the half-life extenders or the lyophilizing extenders in the cake. And so there's nothing in it. And sometimes they probably get like arginine or, you know, some sort of salt.

Claudia von Boeselager (28:50)
Okay.

Mm-hmm.

Jay Campbell (29:01)
And again, so when people inject it, there's no negative reaction, but at the same time they don't get benefit because it's not a real

Claudia von Boeselager (29:08)
Yeah. How do people protect themselves? and where would you send them to? And you know, is there even a place to go to nowadays with all this regulatory changes and upheaval happening?

Jay Campbell (29:17)
Yeah, so it's a great question. So there's two options, right? And if you're gonna go down a compound pharmacy and you're gonna get a script from a doctor, which a lot of people want to do, because obviously if you do that, you don't have to worry about reconstitution, about acquiring bacteriostatic water and syringes, etc. Because obviously the doctor or I shouldn't say the doctor, it's important today to say the prescriber, right? Because you have NPs, nurse practitioners, you have physicians' assistants who are legally prescribers.

So again, the prescriber will provide everything so that it's almost done for you. But again, if you're getting it done for you, that's perfectly fine and acceptable, but just expect to pay seven to ten times the cost. That's just with that's the markup. But if you're going to go the research route and you're going to buy from like biolongevity labs or you're going to buy from you know core peptides or you know, again, atomic labs, one of the legit companies, simple peptides, just make sure that you are vetting their products through their batch and lot numbers, which are easily traceable.

Which are easily researchable online, which you can easily verify is legit. You can call the manufacturer of the company that tests them, and you can say, hey, is BioLongevity Labs, Atomic Labs, Simple Peptides actually paying you to test their products? And they will say, Of course they are. And here's the batch of lot numbers because it's a real business. But you have to do that if you're buying from research, because 75% are probably fake. And that's the scary part. And so, you know, all those companies, as you know, Claudia, are targeting you on Instagram.

Claudia von Boeselager (30:28)
Mm-hmm.

Jay Campbell (30:40)
Or they're targeting you on TikTok, or they're targeting you on Facebook, or they're targeting you all over the place. And again, it's a joke because listen, this is the truth. I haven't told anybody on this a podcast because I found this out from Jeff on Friday of last week. You're the first podcast I've done this week. They're saying now that for every nine hours a day that goes by in a business, 20 research peptide companies form. So it is an absolute

Claudia von Boeselager (31:02)
Wow.

Jay Campbell (31:05)
Unmitigated circus and there is no enforcement right now. You know, again, the FDA can't really enforce peptides in the research space because they don't have a purview. What they can do is obviously come after you if you make claims. if you are selling, you know, again, non approved FDA products like retitrutide, like trzapatide, like semi glutide. There are other biologics a lot of these guys are selling.

we don't do that in my company. we sell literally research peptides and obviously we sell the oral nutraceuticals and the bioregulators, which again are all perfectly legal, perfectly acceptable. and we don't play in that game. But if you are playing in that game and you are making claims, then you have a real problem. And I think a lot of people, unfortunately, in social media today are doing that because they're not educated. They don't have an attorney. I mean, look, you see this. There are literally moms selling peptides out of the back of their car.

Right. Like they started using glow or they started using clo or they started using, you know, one of these peptides for beauty and longevity. And they're like, Wow, you know, I'm an expert. I can start selling this on the back of my car at my SMESPA.

Claudia von Boeselager (32:01)
Yeah. Yeah.

Jay, if I told you like I can't walk in my gym or like, I mean, no matter where I'm going, and it's like peptides and like I heard about this and I heard and Motsy and should I be taking and I it's just wild how little information people are accepting before injecting themselves with things. And I'm like, Do you even know what this is? Like, you know, how much information My friend sent me a video on TikTok. I'm like,

Jay Campbell (32:27)
see, this is again to the benefit of the people that are doing this. They're so innocuous and they're so harmless in most use case examples. I mean, obviously, I do want to say, you know, the caveat is the GLPs, right? Because the people with the GLP nonsense, as I always say, 95% of people use GLPs incorrectly, sparsely when they start it, because they follow the pharmaceutical package insert.

six milligrams for Tirzepatide or eight milligrams, or ten milligrams for Retatrutide I mean, it's literally insane. And so all these people that start with that blow out their receptors. Obviously, you know that they're not watching your show or they're not watching people like me. They don't understand about all the you know things they have to do about eating enough protein, being hormonally balanced, you know, provide doing resistance and cardiovascular training, living in some controlled. Right. They have zero foundations.

Claudia von Boeselager (33:11)
Yeah.

Jay Campbell (33:11)
And

so all the negative side effects and all of the Wagovi face and the Wagovi neck and the Wagovi butt, all the muscle collapse, it all happens, it's all real. But it's all easily controlled and avoided if they have the education on how to use these products. And as you and I both know, I'll just say it straight up. I mean, you have to microdose. You have to learn what a microdose is. You know, if you're using a doctor prescribed compound version, you know, what the dose is from them versus if you're using research.

Claudia von Boeselager (33:29)
Mm-hmm.

Jay Campbell (33:39)
You know how to calculate, reconstitute it, don't know the difference between milligram and microgram, understand whether you're gonna inject two or three times a week. I mean, it's work. So it's like exactly the the research side has to be, as I say, empowered, sovereign, and autonomous. And on the other side, you're pretty much externalizing a little bit of your power to doctor for safety. But again, it's gonna cost you more money. And and the truth is it just comes down to you as the end user, as the patient, as the researcher.

Claudia von Boeselager (33:48)
There's nuances, yeah.

Jay Campbell (34:07)
what you choose. I mean, obviously I've been teaching people for 20 plus years how to be sovereign when using them, but at the same time, I don't have a problem if a if a consumer slash patient wants to get it from a doctor. What I care about, and this is what obviously we're doing now with the American Peptide Association, you know, Jeff Cohen and his company, I'm on the board, is to create a governing standard that will triple authenticate and certify any peptide.

Right. So it's like you're gonna have every peptide, whether it's compounded or researched, will be tested by the manufacturer. And then it will be independent third party will then test for heavy metals, toxins, endotoxins, lipopolysaccharides, contaminants, etc. Anything that could be in it. And then you have another third independent party come in and certify those two. So if you have three independent parties certifying and verifying.

Claudia von Boeselager (34:53)
Mm-hmm. Excellent.

Jay Campbell (34:58)
You're really going to avoid a lot of the issues that currently the marketplace doesn't have. And that's one of the things that we're doing at American Peptide Association. And we're obviously working very, very hard to make the sure that this is all, you know, in place, hopefully by the end of first quarter next year. But the problem is, I told you this on the last one, and I'll say it again now, is Calley Means told me this. This is his exact words to me in Vegas last year in December at the Longevity Fest in Vegas. He said, He listened to me. He's a really awesome guy. Shout out to Cali. You know, he's very close to

Claudia von Boeselager (35:12)
Excellent.

Jay Campbell (35:26)
RFK. He said after he listened to my whole spiel, he said, you know what, dude? He said, The problem with you is that you guys do not, meaning research, you don't have a seat at the table. And Lily owns the table. Right? Because again, they are the biggest lobbyists and supporters of the United States Congress and Senate in the world. So I mean, bottom line, they can pay off and bribe anybody they want for anything at any time, and that's fine. That's how politics works. But

Claudia von Boeselager (35:27)
Mm-hmm.

Jay Campbell (35:52)
At the end of the day, once I heard that and I went to Jeff, which was in the middle of December of last year, in the middle of us not knowing whether we had a future or not, I said, dude, we gotta figure out how we can get a seat at the table. Like we have to create something that will create enough friction and enough movement and obviously get senators and high-level people involved so that we do have a seat at the table. So how fast we get a seat at the table, Claudia, I don't really know. I mean, again, we're a small body.

But we have a lot of big movers and shakers that are involved in this right now. So our hope is that we will have this, like I said, this triple authentication certification, you know, at some point in the first quarter of next year so that we can at least assume that as like the overlordship standard on looking at peptide quality, manufacturing quality, so that we can avoid the bad actors. Because like I said, I'm telling you, 75%. And again, a lot of the people that are smarter than me in this space say, dude, you're underestimated.

You know, are bad actors. And again, they're selling fake certificates of authenticity, they're selling underdose products. And look, I don't think all those people are bad. I think that they are, you know, starting well intentioned, but because they're buying from China and they're buying from bootleggers, you know, let's say they buy a hundred vials of one product and 90 of them are legit and 10 are fake.

Claudia von Boeselager (36:45)
Mm.

And they don't know how to test for the difference. Yeah.

Jay Campbell (37:11)
Exactly.

Over time, as you start instituting these into your inventory model, you're selling underdose and fake product. And again, that's the story of drugs, you know, since the beginning. You know, you start off with a pure product that's 100% and then it gets cut and then it gets degraded and then it gets diluted. And then eventually people aren't getting what they think they're getting. And I would say that that's exactly what has happened in the peptide space in the last three years. A hundred percent.

Claudia von Boeselager (38:21)
Jay, for people potentially listening, you know, maybe there's someone that could support or

help, what would be helpful for the American Peptide Association and that triple testing that you're discussing, which I think makes so much sense. And like how do you set the gold standard? And I've had some stem cell exosome experts on too, and they're saying this is also there's these bad actors that are causing so much issues in the space, whereas when you're trying to do it right, it's just so frustrating.

Jay Campbell (38:39)
Yes, yes.

Claudia von Boeselager (38:44)
What would you say is needed to expedite that process, to get the seat at the table, to really have the right people listening for the benefit of all people who need these peptides essentially?

Jay Campbell (38:55)
I mean, the real answer is money, you know. the good news is that a lot of us are doing well enough that we have enough influence collectively that we can kind of, you know, as they say, get your back scratched. So I feel like the process is happening slowly, collaboratively, you know, over time, methodically is probably a better word too. But you know, if you're a

person, and I know you have a lot of heavy hitters that watch this, who's interested in getting in the space, you know, reach out to me because obviously I can connect you with the people that are running the American Peptide Association. I mean the good news is there are some very, very high-level people that are aware of the American Peptide Association who are clearly in interested in seeing, you know, peptides being able to be outsourced to the world, so to speak, and not to be, you know, these Machiavellian restrictions that clearly pharma wants. Because look,

At the end of the day, and I have a lot of respect for Eli Lilly and the people that make their products are the smartest people in the world, but they do not want the globe healthy. They want to make money. They are a trillion dollar company because the bottom line is the bottom line. they're not interested in seeing people become healthy, right? Like if they were, they would be teaching with the package inserts microdoses. That's just not how it works.

So again, I don't blame them. I say people like me, people like you, other doctors who are starting to get really smart about this, it's up to us to teach people that peptides are literally just tools. And so the difference between maximizing their value and causing horrible side effects, which is obviously the majority of people using GLPs are experiencing that, is the education. And so we now have to do a really, really good job of teaching people that they're not magic bullets.

They're not exercise in a bottle. They're not easy buttons. They're literally tools that any smart, conscious human being can use when they have the actual foundational precepts dialed in, which again is lifting weights, you know, eating enough protein for your goal body weight, being hormonally balanced and optimized, mitigating EMF, getting quality sleep, blah, blah, blah. All those things that you and I know that we talk about every day, most people don't.

Claudia von Boeselager (40:54)
Thank you.

Jay Campbell (41:00)
And too many people think that peptides are these magic bullets because they saw some influencer on TikTok, Instagram, or YouTube screaming, I look like this because I use glow peptide. And by the way, you can buy it from me with 20% off code. You know, I mean it's literally insane, but the truth is that there are amazing molecules. They do work, they are transformative.

But again, if you don't understand how to use them and you're not doing all the things foundationally, they're not going to do anything for you. And again, I've seen more people use peptides who were not doing all the things unravel and come back to people like me or my wife or whatever and say, like, they don't work. Jay Campbell's a scam artist. You know, and there are a lot of people that have that experience. And it's because, again, they don't understand how to use these things. And again, the medical profession doesn't either. You know, by and large.

They're getting their instructions from the pharmaceutical companies and the package inserts. So, again, if you are an end user and you are using a physician, make sure your doctor, same thing I used to say for hormones for 15 years, make sure your doctor prescribes peptides and hormones and has been doing so for at least five to 10 years successfully with men and women and has a giant experiential body of work to prove it. Don't just go to some, you know, Johnny come lately.

Functional medicine person who says they can help you because you're not going to get the same effect. And again, it's incredible. what I dealt with in the last two days, Claudia, with the rejection of helping Chris Johnson has just blown me apart, you know, mentally, because I'm like, my God, I thought we were in a different time. But again, the corporate money machine that governs professional athletics.

Claudia von Boeselager (42:21)
Mm-hmm.

Jay Campbell (42:38)
Entertainment, you know, all the high levels, you know, what do you call they call it Gaslighting. I mean it's just it's so insane what they're doing right now still at these companies because again, they can't make money off of

Claudia von Boeselager (42:49)
yeah, I agree. And then also the lack of education, as you said And so then they'll read the CVS article and they'll be like, well, look, I mean, these are terrible and they're fake. And but that's propaganda, frankly, if you ask me, you know, it's literally modern day propaganda. And when you also read some research studies, it's follow the money. Who paid for the research study? How big is the cord? Is it double blind placebo? Like, can you really judge it as neutral research? Yes or no? And so

I think educating people to understand, like you have to look behind, always be suspicious until proven otherwise. I think is so, so, so important. so peptide that's huge topic, huge space, so much interest, and you're so knowledgeable on this and explaining it Let's touch back on the supplements in a little bit more in general. so also that is an industry that is essentially broken.

Why is that Jay? And what do people need to 'cause everyone's like, I'm

taking my supplement and I must be doing well. I don't notice a difference. Supplement is a supplement or let me buy them on Amazon. I saw some deal and like, you know. yeah. So can you help people understand better

Jay Campbell (43:43)
don't know if I've ever really talked about in this level the way that I want to about supplements. Cause obviously I've been in the supplement space for 30 years. you know, full disclosure, I had a supplement company at one time that I bought out of, or I actually I asked my partners or three of us to buy me out because I didn't want to do business with them anymore. It wasn't because I didn't like them, it was because I knew that the supplement industry was so shady. And what I mean by that is I'll explain and then we'll get into like the stuff that I sell. But almost every supplement company.

sells products that they buy from a wholesale manufacturer somewhere, you know, either in China, India, or US. There is a lot of supplements being made in the United States right now. And as you know, there's no governing or quality control. There's no FDA, there's no regulatory body or agency that looks at supplements to verify their sterility processing control. And so if you know that and you're working in that space,

You could literally buy a batch of let's say vitamin C from this manufacturer in New York, White Plains, New York, because that's a huge manufacturer right there, I will say, and they will send you your first batch and it will test out at 99.9%. And it cost you a lot of money to test that first batch, right?

So what happens in the space, because I've experienced this firsthand, and everybody who's in the supplement space who's listening to me right now is going to laugh because they know this. What happens over time is as a manufacturer, you start playing the profit and loss game. And eventually you get to a batch where you're like, I'm not going to pay to test it. I trust the manufacturer because they've been always sending me 99.9%. And so the manufacturer also knows that you're not paying to test it anymore. And so that's when the game starts happening and they start cutting your product.

Or they start diluting it or whatever. And again, I don't even want to accuse anybody of anything, but believe me, majority of people who buy supplements are not getting anything close to what the label claims are getting. And again, is that the fault of the actual seller of the product or is it the manufacturer? Is it both? Doesn't matter. It just, I know, and most people should know, because there's no governing body, because there's no testing, there's no regulatory oversight, there's no sterility processing control.

The likelihood that you're being scammed is very high. And by the way, this is what's happening in the peptide space now, right? So it's the same thing. So if you are a person who buys supplements, at the end of the day, you probably realize that your supplement that you're buying is not very expensive, right? And that's because the system has created this expectation of like easy come, easy go, or easy purchase, you know.

Claudia von Boeselager (46:02)
Yep. Mm-hmm.

Jay Campbell (46:22)
understand you might get something, you might not get something. And so everybody who buys supplements buys them for relatively a discount or an economically affordable and viable price on Amazon, right? You know, put Ashwagonda and go on Amazon. You'll see like a hundred different manufacturers, right? And it's like, well, wait a minute, they all say they're 100% and they all say they're coming from the African sapinent tree or whatever. And so it's just like, wait a minute, right?

Claudia von Boeselager (46:38)
The buzzwords Yeah.

Mm.

Jay Campbell (46:48)
And that's exactly what you're at. And that's why the pricing on all these things is pretty pretty cost efficient relative to if you go buy supplements from Jay Campbell, who's selling literally peptides, small molecules, bioregulators, which by the way, are not proprietary blends or I mean some of our blends, like our peptide blends, are not proprietary blends, but they're mixes of different peptides. But at

Very high milligram dosage, standardized milligram dosages. So it's hard for the average supplement slash buyer slash consumer to justify spending $300 for BioGut Pro when they can buy some, you know, again, diluted, literally probably undercut or just some sort of proprietary blend product that also says they help with gut health for $39.99 on Amazon. And they're both a month's supply, right?

So that's like the big difference. So you, as the end user consumer, have to do your due diligence, and you have to understand that if you're buying from level up or you're buying from bio longevity labs, which again, I only say those two companies because I think we're the only two companies on the planet right now that are selling the small molecule peptide-based blends. I know there's some research companies are selling stuff similar, and so I don't want to like leave them in the dust, but from a volume standpoint, we're the two biggest. And it's like

You gotta look at the price and you gotta look at what's in the actual label ingredients. And again, I know Kyle, I know he's not a scammer. I know his products are legit. I've used them myself. So it's like if you sort of looking at his products, you look at our products and you see the cost, and there's a little difference in some of them. Some of them have lower doses, and some of ours have lower doses. Some of them are 120 capsules, 30 capsules, 20 capsules for bioregulars, et cetera. So it's a smaller dose versus a month or two months. it's just a huge divergence, it's a gulf in price.

Claudia von Boeselager (48:36)
Mm-hmm.

Jay Campbell (48:36)
Right.

And again, it's because we're selling legitimate peptides that are tested, that are verified, that are understood to have the exact label claims. And again, so we've now entered a space where there isn't a standard, there isn't a governing body. We're just literally upheld to the same standard we have as a research chemical company, where there is, where you do have to be tested, where you do have to verify label claims and accuracy and sterility processing control. So

That's kind of what's happened with our supplement products. And very truthfully, as owners, you know, we don't know how long we can continue to sell at the price that we're selling at right now from a profit margin standpoint, because we don't know if the American consumer, and as you said earlier, the global consumer will actually spend the money that's relative to the profit margin of our products because they're so high quality. So there may come a point in time where we're just gonna have to be like, guys, we you know, I'm not gonna say we're gonna hoard the products out, but

Claudia von Boeselager (49:25)
Yeah.

Jay Campbell (49:31)
You know, we may not be able to make the margin that we're used to making coming from the research side because most people are not going to pay that amount of money. And it's really sad that that's the supplement industry. And so there's nothing you can really do. We cannot you know create a new industry. We can't scale a new model. I mean, maybe at some point, if you know American Peptide Association does create that standard, you know, and we can stand behind that standard, which we obviously would, maybe that would allow us to keep our margins and keep our prices where they are. But I mean I'm telling you,

We're not ripping people. We're not ripping people's heads off. Like we're running a profitable business. And as you know, you have to have a minimum margin, you know what I mean, to succeed, to pay your payroll, to make sure that the people that work for you ship. you know, we test and all that stuff. So it's like we're not ripping people off. we're obviously a good company, but we're not in it to like line our pockets and not help people. So it's a little bit harder to sell those products right now in a market where so many people are used to buying again, underdosed, low quality.

you know, call it commoditized products because that's what Amazon and eBay and you know even I would say Alibaba have created. They've just created these giant commoditized warehouse, you know, marketplaces.

Claudia von Boeselager (50:33)
eBay.

It brings up the analogy with almost like fashion, right? So previously, like my father would go to his store that I mean, he's eighty eight years old now and buy something. And literally he still has this piece of clothing from like 40 years ago because the quality is so excellent. And yes, you pay a bit more, but if you get really high quality. But you have all these people used to fast fashion now. It's all about the price and quick and turnover, et cetera. And I think that's the real difference, is that

You're investing in your health. It's almost like a tax on your health that will benefit you for a very, very long time. So rather invest a little bit more now and get the actual benefits and the outcome than almost potentially poisoning yourself with some random ingredients that you don't know what's in there because it's not regulated And so looking for those quality sources. Jay, what would you recommend people like reading the label? What should they look out for? And how should they be reading it to really be able to assess, is this good? Is this not good?

Jay Campbell (51:26)
Yeah, that's a great question. So, like I'll give you BioGut Pro, for example, like our product. So, BioGut Pro is a microbiome, inflammation suppression, just improving everything of gut health. And it has six different products, right? There's like four peptides, carnosin, PEAA, just you know, efficacy extenders, absorption enhancers, etc. But every single thing is labeled with an amount with a milligram amount.

And so when you buy a supplement, especially when it has a blend like that, you know, we have a couple of other products that are blends like Biorestore, which is a very high formatted version of BPC 157 and Arginine Salt. And then we also have BioMind, which is three nootropics. But you have to understand what is the ingredient listed. What is the active ingredient dosage? Most companies, especially in the supplement industry, of which we just talked about.

Will put what are called proprietary blends and they list the name of the product and you don't know what the active amount of the ingredient is. So you don't know if you're getting anything active. And I'll be honest with you, you're probably not. So that's what ends up happening with people. You know, the same thing like with GHK. There's tons of women's fashion and skincare companies selling products that say,

It has the GHK or the Clow or the Glow or whatever blend in it. And then you look at it and it's a proprietary blend and there's no ingredients. And again, you know, before I sold my last company, we were one of the first companies on the planet was called a Seer Custom that actually had patents on our hair product and our fish serum and cream. And again, it was all GHK placed. And we knew from being in the system and being in the space that you had to have a 3% grade or better. And at the time 3% was the highest. Now we have six and ten.

And by the way, do not under any circumstances, ladies, put 10% GHK on your face if you don't want to be burned. I mean, it'll work amazing, but it will burn your skin because it's such a powerful active ingredient. But if you don't have 3% active ingredient or higher of GHKCU in a you know skincare tonic or hairy growth blend, it's worthless. I can already assure you it's worthless. And not only is it worthless, if it's not listed as 3%, it's way less.

And it is a proprietary blend. And so that's how these companies get away with scamming people is they just list all these hot button matrixel snappay, you know, all these like high gloss words that are yes that are actually searchable on Google, right? And they'll so they'll put them on the label and then there'll be no active ingredient. And so legally they can get away with that. Because even if they just put a smidgen, and when I say a smidgen, it's like worse than a gnat's ass, right? Amount.

Claudia von Boeselager (53:35)
Mm-hmm.

Yeah.

Mm-hmm. Mm-hmm.

Jay Campbell (54:01)
They put into that thing. And so it's like they say that, but then you go to test it and you're my God. So that's what's happening. So you know, to the original question, like, make sure the bottle shows the active milligram amount on the label of the blend. Like, you know, for example, our bio mine has J147, it has dihexa, which is a peptide, and then it also has nupept, which is a racetam. So it's three very, very powerful nootropic.

you know small molecules and peptides and they're all studied. There's lots of research on all three of them and it has the active ingredient of each product. So if you wanted to test it, be my guest, you know it's gonna cost you a lot of money to test it if you want to get those three blends out of there and understand the active ingredient, but you can, and it's gonna be very, very close to what we say it is. And of course that's also why it works.

So again, I think we have to say that if you use any of the biolongevity lab oral products, there is no way, with maybe the exception of some of the bioregulators, which as you know, they just kind of optimize, they're like maintenance products. But none of our small molecules, you will not know that it's working or that you're experiencing something noticeable to the five senses within a week. Because again, all of the products are designed to do what we claim on the label they do, right? Shred max.

Is 100 milligrams per capsule of SLUPP-332, which is a very powerful mitochondrial mimetic and you know, essentially exercise in a bottle. And if you use as a woman 100 milligrams a day, or as a man three or four hundred milligrams a day, you will know in three days that it's working. You're gonna be stronger, you're gonna be sweating more, you're gonna be just more energetic when you're lifting or doing cardio. So it's like again, you have to know as a consumer.

Claudia von Boeselager (55:33)
Well.

Jay Campbell (55:44)
Have to have a little bit of self-internal awareness, right? You got to understand your body and what's happening to you, but you're gonna know pretty fast with any of our small molecule products, and I would say most of our bioregulators too. I kind of hold back on some of them because again, they're very maintenance stuff. Like if you take this product, which I think is what I'm taking right now, biopineal, in two weeks, you're probably gonna be a little bit more clear-headed, you're probably gonna have a little bit deeper sleep because again, it's going to restore.

Claudia von Boeselager (56:02)
Mm-hmm.

Well

Jay Campbell (56:10)
The pineal gland, which as you know is calcified in the majority of us living in modern society. And again, it's not a peptide, it's not like pineal on the injectable peptide, which is profound. This is just a bioregulator, small chain of amino acids, again from the Russians, the Cavinson formulation, double the net ingredient of the blister packs that come out of Russia and Bulgaria, and it will literally help with decalcifying the pineal gland over time. And that may show up to you as just a little bit more clear-headed, a little bit more deeper sleep.

you know, maybe one day you'll awaken to realize that we're governed and controlled by reptilians. I don't know, but it does, it does do very small, subtle things. But all of our small molecule products, which I think we have 11, maybe 13, 11 or 13, I can't even remember. There's two, there we have 11. There's two more coming. Biopurify is coming, and I forget the name of the other one. But Biopurify is going to be the best oral product on in the entire world that will help people with.

Claudia von Boeselager (56:46)
Ha ha ha.

Okay.

Jay Campbell (57:08)
Atherosclerosis, so obviously clogged arteries, APO, so small particle issues, APOB, little APOA. and also, and dare I say it, it will help cleanse the body of spike protein and graphene oxide because it has a super high level of nato kinase, and it also has a tetrahydrocurcamine format that has been shown in some studies to rid the body of, you know.

chemicals and particulates that people get exposed to in heavy metal situations. So theoretically it stands to reason that if you have high levels of spike protein or graphene oxide from being vaxxed multiple times or boosted multiple times, it will help get rid of that through your system. It's not going to help in overnight, but if you use it over time and you do it for a full year, you will definitely notice benefit. And so that's coming. But again, all of our oral products the small molecule formats, you will know something in a week without a doubt from using

Claudia von Boeselager (57:46)
Mm-hmm.

So I want to ask you what your top three to five are for people listening. What would you recommend that they look at? And I know we've gone slightly over time. And then one question people ask me also with oral supplements. They're like, Well, does it really even make it past the stomach? Does the stomach not destroy it? Is there really an impact So maybe we can just address that before we finish up today.

Jay Campbell (58:15)
Yeah, so let me answer that because that's a great question. So again, this is one thing that blew me away in the 30 plus years that I've been in this space, even when I was in my early 20s and I started studying the design and the manufacturing and also just like the efficacy of you know product, let's just call it dissolution in the body. If you take like a small molecule or maybe a thermogenic supplement.

And you take it with food, it's useless because it will not compete with crossing the blood brain barrier with insulin or any other, you know, caloric, you know, energetic construct of a fat molecule or a protein molecule or even a carbohydrate molecule. So, again, for those types of products, and again, that would be a thermogenic and a small molecule like any of the bio longevity lab small molecules, you gotta take them fasted in the morning when you wake up. So you can

Get them into again, call it just portal circulation or systemic circulation through the gut. And so that it does cross the blood-brain barrier the fastest. But if you were eating while you were taking any of those, you would have zero effect. So that's the most important thing. And some of the bioregulators do say, and this comes from the Cavinson Institute and Dr. Cavinson himself, and also Yana, who's you know gone over this with me, you do want to take them with food because the way they are designed is

they're able to be absorbed with fat. So like they have like an emulsifier around the actual bind of the product. And so they'll absorb better with food than they will on an empty stomach. But trust me, I take them on an empty stomach and I get effect. So I don't think it's that big of a deal. But for most products that you need to cross the blood brain barrier without competition or say call it inhibition with insulin, you definitely gotta take them on an empty stomach. here's my three top products for BLL. The ones that I notice the most.

Claudia von Boeselager (59:51)
Mm-hmm.

Jay Campbell (59:55)
We have so many amazing ones, but Shred Max is a very high dose of SLU PP-332. Women need to take 100 milligrams. Men can take up to 400 to 600 milligrams. Everybody's a different responder to it, but you will notice immediately more sweating, better energy in the gym, more force production, because again, it does do a lot of things with mitochondrial power. the other two that I would say would be most noticeable.

Claudia von Boeselager (1:00:16)
Yeah.

Jay Campbell (1:00:18)
I already mentioned BioGut Pro. I mean, if you have any kind of microbiome issue, autoimmune issue, yeah, like 90% of women in America probably who are not, you know, loving and trusting themselves and doing all the inner work, as my wife would say, that's gonna help a lot because again, it really does cause an improvement in microbiome health and microbiota health. It's gonna do a lot of things. It's also gonna calm inflammation. And obviously, a lot of people have SIBO and they have

Claudia von Boeselager (1:00:23)
Which most people do. Most peop most people do.

Yeah.

Jay Campbell (1:00:46)
you know, candida and other yeast and nasty things growing in their microbiome. So that's gonna dramatically improve that health immediately. Most people that take that notice improvement within 24 to 36 hours, right? So depending on how inflamed you are in your microbiome, you can take six capsules a day and it really helps. And then the other one, which again is one of our oldest, what's we call the OG supplement is BioMind. I mean I don't know anybody who doesn't take one or two capsules on an empty stomach in the morning

that has to speak, that has to lecture, that has to take a test, something that is you know demanding cognitively, that does not see clear. It does not cause jitteriness, it does not stimulate the beta adrenergic system. So there's no heart rate increase, but it definitely makes things much clearer. You just have a real calm, you know, I call it precise focus for four to six hours. So again, start with one capsule.

Once you get used to it, take two. Do not take it every day. Obviously, it's just something when you have really intense, demanding cognitive tasks that you need to perform. That's when you take it. But I love that product and I never travel anywhere without it, especially when I have to do an amazing interview like with someone like you. Which by the way, I'm not on it today because I don't have any.

Claudia von Boeselager (1:01:52)
And you're so sharp.

It's so naturally built up now in this stage of your system as well. Jay, thank you so, so much for coming back on dear audience. biolongevity supplements are providing twenty percent off with code Claudia20 So make sure to take advantage of that and check them out It's biolongevity supplements.com, Claudia twenty for twenty percent off. Jay, do you have any parting thoughts, message, or advice for my audience today?

Jay Campbell (1:01:59)
But

Great question. yes, my parting thoughts are thank you for listening. Thank you for listening to Claudia. She is a bright light in this world. Remember, your thoughts create your reality. So make them focused, make them positive, and always make them actionable. Do not wake up in the morning with negative thoughts and processes, even though we all do at times. Just remember to get back into the positive mental frequency. Because again, if our thoughts create a reality, why would we want to have negative thoughts?

Claudia von Boeselager (1:02:45)
Beautiful. It's a choice. So, with that, dear audience, thank you so much for tuning in, Jay. Such a pleasure to have you back on. Thank you so much for sharing your wisdom.

Jay Campbell (1:02:52)
Thank you so much, Claudia. I appreciate it.